# OnCo record etx-929 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/etx-929/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "etx-929" ;
  schema:name "ETX-929"@en ;
  schema:description "ETX-929 is an experimental small molecule from Ensem Therapeutics, in phase 1 trials for metastatic colorectal cancer, pancreatic ductal adenocarcinoma and non-squamous non-small cell lung cancer and other cancers."@en ;
  schema:url <https://onco.cc/drugs/etx-929/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://ensemtx.com/science/pipeline/>, <https://clinicaltrials.gov/api/v2/studies/NCT07912593>, <https://clinicaltrials.gov/search?intr=ETX-929> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Small molecule (oral capsule)" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/ovarian/> ;
  onco:targets <https://onco.cc/targets/kras/> ;
  onco:companies <https://onco.cc/companies/ensem-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct07912593/> .